Carrier advocacy coverage letter for Preoperative, image-guided botulinum toxin injection for hernias

The evidence-based letter for preoperative, image-guided botulinum toxin injection (“chemical component separation”) to optimize fascial closure in patients undergoing repair of large or complex ventral or incisional hernias was written by IR physicians who are members of SIR's Carrier Advocacy Workgroup. The letter is intended to help IRs during the authorization, appeal or denial process with any payor denying this service.

Policy coverage topic: Preoperative, image-guided botulinum toxin injection (“chemical component separation”) to optimize fascial closure in patients undergoing repair of large or complex ventral or incisional hernias.

A subscription model applies to this product. The text, graphics and information are of a general nature; it is not a substitute for obtaining medical advice. We may update the documents at any time without prior notice.